Author: Per Lundström

Additional PBPK publication

Our Pharmetheus colleague Erik Sjögren is co-author to a new publication on physiologically based biopharmaceutics models. This workshop report summarizes the proceedings of Day 1 of a three-day workshop on “Current State and Future Expectations of Translational Modeling Strategies to Support Drug Product Development, Manufacturing Changes and Controls”. Link to publication.

Read More »

Welcome Fanny Gallais!

We are happy to have Fanny onboard as a MIDD consultant. Her research experience includes PK/PD modeling and simulations of preclinical and clinical data in

Read More »

Welcome Andrea Henrich!

We are happy to have Andrea onboard as a MIDD consultant. Her research experience, from academia as well as pharmaceutical industry, includes PK/PD modeling and simulations in different therapeutic areas and concentration-QT analysis. Andrea will work from our Basel office in Switzerland. See her bio here

Read More »

New MIDD publication

Read more on the importance of collaboration for successful implementation Model Informed Drug Development. Richard Anziano, Chief Statistician and Peter A Milligan, CEO at Pharmetheus gives their perspective on this topic in the latest issue of Clinical Pharmacology & Therapeutics.Link to publication

Read More »

New PBPK publication

Our Pharmetheus colleague Erik Sjögren is co-author to a new publication on physiologically based biopharmaceutics models. This workshop report summarizes the proceedings of Day 1 of a three-day workshop on “Current State and Future Expectations of Translational Modeling Strategies to Support Drug Product Development, Manufacturing Changes and Controls”. Link to publication.

Read More »